The LRRK2 WDR domain is an understudieddrug target for Parkinson’s disease, with no known inhibitorsprior to the first phase of the Critical Assessment of ComputationalHit-Finding Experiments (CACHE) Challenge. Here, LRRK2 is linked to Parkinson disease.